Table 1. Annual surveillance data and rates of central line-associated bloodstream infection.
| 2011 | 2012 | 2013 | 2014 | Total | |
|---|---|---|---|---|---|
| Annual totals (n) | |||||
| Discharges | 120 | 339 | 240 | 274 | 973 |
| Patient days | 1280 | 2633 | 2603 | 3326 | 9842 |
| Central line days | 1201 | 2566 | 2564 | 3294 | 9625 |
| Device utilization ratios | 0.94 | 0.97 | 0.99 | 0.99 | 0.98 |
| Annual CLABSI rates | |||||
| Overall CLABSI | 9.99 | 5.07* | 4.68 | 5.48 | 5.72 |
| MBI-LCBI rates (per 1000 CL days) | 4.16 | 2.73 | 2.34 | 1.83 | 2.50 |
| Non-MBI-LCBI rates (per 1000 CL days) | 5.83 | 2.34* | 2.34 | 3.65 | 3.22 |
CLABSI= central line-associated bloodstream infection, CL=central line, MBI= mucosal barrier injury, LCBI=laboratory-confirmed bloodstream infection.
*
These proportions changed significantly from the previous year (P<0.05).